PPP1CA and hepatocellular carcinoma: To further evaluate the role of PP1A in immunotherapy, particularly in the TME of HCC, we established subcutaneous syngeneic tumor models using Hep53.4 cells in C57/BL6 mice and carried out single‐cell sequencing.